Literature DB >> 19206471

NMR second site screening for structure determination of ligands bound in the hydrophobic pocket of HIV-1 gp41.

Edina Balogh1, Dong Wu, Guangyan Zhou, Miriam Gochin.   

Abstract

The development of nonpeptide fusion inhibitors through rational drug design has been hampered by the limited accessibility of the gp41 coiled coil target, which is highly hydrophobic, and the absence of structural data defining details of small molecule interactions. Here we describe a new approach for obtaining structural information on small molecules bound in the hydrophobic pocket of gp41, using a paramagnetic probe peptide which binds adjacent to the pocket along an extended coiled coil. Ligand binding in the pocket leads to paramagnetic relaxation effects or pseudocontact shifts of ligand protons. These effects are distance and/or orientation dependent, permitting determination of ligand pose in the pocket. The method is demonstrated with a fast-exchanging ligand. Multiple measurements at different coiled coil and probe peptide ratios enabled accurate determination of the NMR parameters. Use of a labeled probe peptide stabilizes an otherwise aggregation-prone coiled coil and also enables modulation of the paramagnetic effect to study ligands of various affinities. Ultimately, this technique can provide essential information for structure-based design of nonpeptide fusion inhibitors.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19206471      PMCID: PMC2880620          DOI: 10.1021/ja8094558

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  15 in total

Review 1.  Mechanisms of viral membrane fusion and its inhibition.

Authors:  D M Eckert; P S Kim
Journal:  Annu Rev Biochem       Date:  2001       Impact factor: 23.643

Review 2.  Resistance to enfuvirtide, the first HIV fusion inhibitor.

Authors:  Michael L Greenberg; Nick Cammack
Journal:  J Antimicrob Chemother       Date:  2004-07-01       Impact factor: 5.790

Review 3.  HIV entry inhibitors targeting gp41: from polypeptides to small-molecule compounds.

Authors:  Shuwen Liu; Shuguang Wu; Shibo Jiang
Journal:  Curr Pharm Des       Date:  2007       Impact factor: 3.116

4.  Small molecules that bind the inner core of gp41 and inhibit HIV envelope-mediated fusion.

Authors:  Gary Frey; Sophia Rits-Volloch; X-Q Zhang; Robert T Schooley; Bing Chen; Stephen C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-08       Impact factor: 11.205

5.  A novel fluorescence intensity screening assay identifies new low-molecular-weight inhibitors of the gp41 coiled-coil domain of human immunodeficiency virus type 1.

Authors:  Lifeng Cai; Miriam Gochin
Journal:  Antimicrob Agents Chemother       Date:  2007-04-23       Impact factor: 5.191

6.  Structure determination by restrained molecular dynamics using NMR pseudocontact shifts as experimentally determined constraints.

Authors:  K Tu; M Gochin
Journal:  J Am Chem Soc       Date:  1999-10-13       Impact factor: 15.419

7.  Molecular modeling studies of N-substituted pyrrole derivatives--potential HIV-1 gp41 inhibitors.

Authors:  Cátia Teixeira; Florent Barbault; Joseph Rebehmed; Kun Liu; Lan Xie; Hong Lu; Shibo Jiang; BoTao Fan; François Maurel
Journal:  Bioorg Med Chem       Date:  2008-01-28       Impact factor: 3.641

8.  Structurally altered peptides reveal an important role for N-terminal heptad repeat binding and stability in the inhibitory action of HIV-1 peptide DP178.

Authors:  Yael Wexler-Cohen; Benitra T Johnson; Anu Puri; Robert Blumenthal; Yechiel Shai
Journal:  J Biol Chem       Date:  2006-02-01       Impact factor: 5.157

9.  Interhelical interactions in the gp41 core: implications for activation of HIV-1 membrane fusion.

Authors:  Shilong Wang; Joanne York; Wei Shu; Marisa O Stoller; Jack H Nunberg; Min Lu
Journal:  Biochemistry       Date:  2002-06-11       Impact factor: 3.162

10.  Novel techniques for weak alignment of proteins in solution using chemical tags coordinating lanthanide ions.

Authors:  Takahisa Ikegami; Laurent Verdier; Peyman Sakhaii; Susanne Grimme; Barbara Pescatore; Krishna Saxena; Klaus M Fiebig; Christian Griesinger
Journal:  J Biomol NMR       Date:  2004-07       Impact factor: 2.835

View more
  15 in total

Review 1.  Biochemistry and biophysics of HIV-1 gp41 - membrane interactions and implications for HIV-1 envelope protein mediated viral-cell fusion and fusion inhibitor design.

Authors:  Lifeng Cai; Miriam Gochin; Keliang Liu
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

2.  Discovery of entry inhibitors for HIV-1 via a new de novo protein design framework.

Authors:  M L Bellows; M S Taylor; P A Cole; L Shen; R F Siliciano; H K Fung; C A Floudas
Journal:  Biophys J       Date:  2010-11-17       Impact factor: 4.033

Review 3.  Paramagnetic labelling of proteins and oligonucleotides for NMR.

Authors:  Xun-Cheng Su; Gottfried Otting
Journal:  J Biomol NMR       Date:  2009-06-16       Impact factor: 2.835

Review 4.  Computational methods for de novo protein design and its applications to the human immunodeficiency virus 1, purine nucleoside phosphorylase, ubiquitin specific protease 7, and histone demethylases.

Authors:  M L Bellows; C A Floudas
Journal:  Curr Drug Targets       Date:  2010-03       Impact factor: 3.465

5.  Development of indole compounds as small molecule fusion inhibitors targeting HIV-1 glycoprotein-41.

Authors:  Guangyan Zhou; Dong Wu; Beth Snyder; Roger G Ptak; Harmeet Kaur; Miriam Gochin
Journal:  J Med Chem       Date:  2011-10-03       Impact factor: 7.446

Review 6.  Amphipathic properties of HIV-1 gp41 fusion inhibitors.

Authors:  Miriam Gochin; Guangyan Zhou
Journal:  Curr Top Med Chem       Date:  2011-12       Impact factor: 3.295

7.  Paramagnetic relaxation assisted docking of a small indole compound in the HIV-1 gp41 hydrophobic pocket.

Authors:  Miriam Gochin; Guangyan Zhou; Aaron H Phillips
Journal:  ACS Chem Biol       Date:  2011-01-07       Impact factor: 5.100

Review 8.  Development of Small-molecule HIV Entry Inhibitors Specifically Targeting gp120 or gp41.

Authors:  Lu Lu; Fei Yu; Lifeng Cai; Asim K Debnath; Shibo Jiang
Journal:  Curr Top Med Chem       Date:  2016       Impact factor: 3.295

Review 9.  Peptides in the treatment of AIDS.

Authors:  Fred Naider; Jacob Anglister
Journal:  Curr Opin Struct Biol       Date:  2009-07-23       Impact factor: 6.809

10.  NMR-assisted computational studies of peptidomimetic inhibitors bound in the hydrophobic pocket of HIV-1 glycoprotein 41.

Authors:  Miriam Gochin; Landon R Whitby; Aaron H Phillips; Dale L Boger
Journal:  J Comput Aided Mol Des       Date:  2013-07-27       Impact factor: 3.686

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.